| Literature DB >> 28704976 |
Xican Li1,2, Yage Tian3, Tingting Wang4,5, Qiaoqi Lin6, Xiaoyi Feng7, Qian Jiang8,9, Yamei Liu10, Dongfeng Chen11.
Abstract
The aim of this study was to explore the role of p-coumaroyl in the antioxidant and cytoprotective effects of flavonoid glycosides. The antioxidant effects of astragalin and tiliroside were compared using ferric ion reducing antioxidant power, DPPH• scavenging, ABTS•⁺ scavenging, •O₂- scavenging, and Fe2+-chelating assays. The results of these assays revealed that astragalin and tiliroside both exhibited dose-dependent activities; however, tiliroside exhibited lower IC50 values than astragalin. In the Fe2+-chelating assay, tiliroside gave a larger shoulder-peak at 510 nm than astragalin, and was also found to be darker in color. Both of these compounds were subsequently evaluated in a Fenton-induced mesenchymal stem cell (MSC) damaged assay, where tiliroside performed more effectively as a cytoprotective agent than astragalin. Tiliroside bearing a 6''-O-p-coumaroyl moiety exhibits higher antioxidant and cytoprotective effects than astragalin. The 6''-O-p-coumaroyl moiety of tiliroside not only enhances the possibility of electron-transfer and hydrogen-atom-transfer-based multi-pathways, but also enhances the likelihood of Fe-chelating. The p-coumaroylation of the 6"-OH position could therefore be regarded as a potential approach for improving the antioxidant and cytoprotective effects of flavonoid glycosides in MSC implantation therapy.Entities:
Keywords: astragalin; flavonoid glycoside; mesenchymal stem cells; p-coumaroyl; tiliroside
Mesh:
Substances:
Year: 2017 PMID: 28704976 PMCID: PMC6152332 DOI: 10.3390/molecules22071165
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of astragalin (A) and tiliroside (B).
Figure 2Dose-response curves of astragalin and tiliroside in various antioxidant assays: (A) FRAP assay; (B) ABTS scavenging assay; (C) DPPH•-scavenging assay; (D) •O2–-scavenging assay. Each value is expressed mean ± SD, n = 3. Trolox was used as the positive control.
The IC50 values of astragalin and tiliroside in various assays.
| Assay | Tiliroside μg/mL (μM) | Atragalin μg/mL (μM) | Trolox μg/mL (μM) |
|---|---|---|---|
| Fe3+-reducing | 246.8 ± 19.3 b (550.5 ± 42.9) b | 465.8 ± 16.3 c (1038.9 ± 36.4) c | 6.8 ± 0.4 a (26.3 ± 1.8) a |
| ABTS•+ scavenging | 57.6 ± 8.9 b (96.8 ± 14.9) b | 170.7 ± 16.0 c (332.4 ± 11.1) c | 8.6 ± 2.5 a (34.3 ± 10.0) a |
| DPPH• scavenging | 138.0 ± 5.6 b (232.2 ± 9.4) b | 144.1 ± 25.1 c (321.3 ± 55.8) c | 6.8 ± 0.9 a (27.4 ± 3.5) a |
| •O2− scavenging | 26.6 ± 2.3 a (44.8 ± 3.9) a | 45.7 ± 3.6 b (102.0 ± 8.0) b | 109.2 ± 8.9 c (436.3 ± 35.9) c |
Note: Each IC50 value was calculated from dose−response curves in Figure 2. The mass units of the IC50 values (μg/mL) were converted to molar unit, and the resulting values are shown in parentheses. The linear regression was analyzed using version 6.0 of the Origin professional software. Each experiment was performed in triplicate, and the IC50 values were presented as the mean ± SD (standard deviation, n = 3). Means values (μM) with different superscripts in the same row were significantly different (p < 0.05). Trolox was used as the positive control.
Figure 3UV spectra of astragalin and tiliroside (A); and the physical appearances of the astragalin-Fe and tiliroside-Fe complexes (B).
Figure 4Ball-and-stick models based on preferential conformation of astragalin (A) and tiliroside (B).
Figure 5Proposed reaction of tiliroside chelating Fe2+.
Figure 6Protective effects of astragalin (A) and tiliroside (B) against the •OH-induced damage of MSCs using an MTT assay. The •OH radicals were generated by Fenton reagent (FeCl2 plus H2O2). These data represent the mean ± SD (n = 5). * p < 0.05 vs model.